drugset / Trial / NCT02428868

IV Iron in Association With Tranexamic Acid for Hip Fracture

NCT02428868 ↗

Unknown 150 enrolled Institut Kassab d'Orthopédie
RandomizedParallel-groupSingle-blindPrevention

Summary

It is a prospective randomized controlled study aiming to test if tranexamic acid combined to intravenous iron before and after surgery for hip fracture in elderly can decrease peri-operative red cell transfusion.

Timeline

Start
2015-04
Primary completion
2016-04
Completion
2016-04

Outcome

Missed primary endpoint

paper The rate of erythrocyte transfusion was 42% with tranexamic acid and 60% with placebo (P=0.06). PMID 19926634 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferroven® Unknown 200 mg Intravenous
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications